Meng Ding
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
- RNA modifications and cancer
Papers in
-
- RNA modifications and cancer 9
- Extracellular vesicles in disease 8
- Circular RNAs in diseases 7
-
- Nanoplatforms for cancer theranostics 19
- Co-authors
- Heng Dong (25 shared papers)Yongbin Mou (21 shared papers)Qiang Li (17 shared papers)Chen‐Yu Zhang (15 shared papers)Yu Zhang (18 shared papers)Cheng Wang (13 shared papers)Dongliang Yang (9 shared papers)Lijun Mao (5 shared papers)
- Journals
- Advanced Healthcare Materials (4 papers)Advanced Science (3 papers)ACS Nano (3 papers)Oncotarget (3 papers)Molecular Cancer (2 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Meng Ding
77 papers receiving 2.2k citations
Meng Ding's Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 471
- Molecular Biology 961
- Periodontics 58
- Biomedical Engineering 604
- Nephrology 83
Countries citing papers authored by Meng Ding
This map shows the geographic impact of Meng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Ding more than expected).
Fields of papers citing papers by Meng Ding
This network shows the impact of papers produced by Meng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Ding. The network helps show where Meng Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Meng Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Biofilm microenvironment-responsive nanoparticles for the treatment of bacterial infection Hit paper breakdown → | 2022 | 160 |
| 2 | 2018 | 138 | |
| 3 | 2016 | 110 | |
| 4 | 2019 | 109 | |
| 5 | 2018 | 101 | |
| 6 | 2017 | 82 | |
| 7 | 2015 | 75 | |
| 8 | 2022 | 72 | |
| 9 | 2020 | 69 | |
| 10 | 2023 | 65 | |
| 11 | 2018 | 62 | |
| 12 | 2023 | 59 | |
| 13 | 2016 | 59 | |
| 14 | 2022 | 58 | |
| 15 | 2018 | 51 | |
| 16 | 2020 | 45 | |
| 17 | 2023 | 44 | |
| 18 | 2023 | 43 | |
| 19 | Therapeutic Applications of Antimicrobial Silver-Based Biomaterials in Dentistry | 2022 | 40 |
| 20 | 2017 | 33 |
About Meng Ding
Meng Ding is a scholar working on Molecular Biology, Biomedical Engineering, Cancer Research, Immunology and Materials Chemistry, having authored 77 papers that have together received 2.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (19 papers), MicroRNA in disease regulation (10 papers), Advanced Nanomaterials in Catalysis (9 papers), RNA modifications and cancer (9 papers), Extracellular vesicles in disease (8 papers), Circular RNAs in diseases (7 papers), Immunotherapy and Immune Responses (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (471 citations), Molecular Biology (961 citations), Periodontics (58 citations), Biomedical Engineering (604 citations) and Nephrology (83 citations). Meng Ding has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Heng Dong, Yongbin Mou, Qiang Li, Chen‐Yu Zhang, Yu Zhang, Cheng Wang, Dongliang Yang, Lijun Mao, Chunhua Yang and Ke Zen. Their work appears in journals such as Advanced Healthcare Materials, Advanced Science, ACS Nano, Oncotarget and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.